Parkinson's disease (PD) is a circuit-level disorder with clinically-determined motor subtypes.
fMRI paradigms (for review, see Herz, Eickhoff, Løkkegaard, & Siebner, 2014) . However, the direction of activation differences in the premotor and primary motor cortices has been notably inconsistent, with reports of hyperactivation (Eckert, Peschel, Heinze, & Rotte, 2006; Haslinger et al., 2001; Lewis et al., 2011; Sabatini et al., 2000; Yu, Sternad, Corcos, & Vaillancourt, 2007) , hypoactivation (Buhmann et al., 2003; Burciu et al., 2015; Prodoehl et al., 2013; Tessa, Lucetti, Diciotti, Paoli, & Cecchi, 2012; Tessa et al., 2010) , and no activation differences (Cerasa et al., 2006; Elsinger, Rao, & Zimbelman, 2003) . Disease stage and medication status at the time of scanning may explain some of these inconsistencies. For instance, hypoactivation of motor areas has been reported in de novo patients (Buhmann et al., 2003; Tessa et al., 2012) , while introducing a dopamine agonist or replacement can lead to somewhat mitigating effects in these motor regions (Buhmann et al., 2003; Herz et al., 2014; Lucetti et al., 2014) . Another possible explanation for the inconsistencies is the practice of combining motor subtypes as a single clinical sample (e.g., Burciu et al., 2015; Spetsieris, Ma, Dhawan, & Eidelberg, 2009) , since the additional heterogeneity may influence outcomes.
Histology, Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography, and conventional BOLD activation fMRI studies have revealed time-averaged, striatal physiology differences that have implicated CSTC network regions in non-TD patient populations (Lewis et al., 2011; Prodoehl et al., 2013) . However, since PD can be considered a circuit disease (Eckert et al., 2006; G€ ottlich et al., 2013; Zhang, Wang, Liu, Chen, & Liu, 2015) that can be modulated by dopaminergic stimulation (Lucetti et al., 2014) and external tasks (Wu et al., 2009) , investigating the dynamic interaction between regions within the CSTC and dopaminergic medication effects could provide new insight into mechanisms of dysfunction during motor demands. Psychophysiological interaction (PPI) is a linear analysis technique that estimates task-induced, dynamic coupling between regions, often referred to as effective connectivity (Friston, 2011; O'Reilly, Woolrich, Behrens, Smith, & Heidi, 2012) . Leveraging the PPI technique could provide novel information about whether CSTC circuit function during tapping differs between subtypes in response to levodopa administration.
In this study, we investigated differences in brain activity between TD and PIGD motor subtypes and age-and sex-matched healthy controls during a paced, finger-tapping task. Given prior evidence that differences in nigrostriatal projection pathology could play a role in the manifestation of motor subtypes (Eggers, Kahraman, Fink, Schmidt, & Timmermann, 2011; Jellinger, 2012; Spiegel et al., 2007) , we hypothesized that task-induced activity within the downstream CSTC network would differ between TD and PIGD subtypes. Further, we examined the effect of levodopa on effective connectivity of the posterior putamen (pPut), a key node in the CSTC motor network (Haber, 2003) , during the tapping task. Since PIGD symptoms are less responsive to levodopa and patients with the PIGD subtype generally require higher doses of levodopa therapy (Vu et al., 2012) , we hypothesized that PIGD patients would show a diminished levodopa-induced effect on motor network connectivity compared to TD patients.
| MATERIALS A ND METHODS

| Recruitment
Twenty-nine PD patients meeting the UK Brain Bank criteria for clinical diagnosis of idiopathic PD (Gibb & Lees, 1988) with Hoehn and Yahr stage I-III were recruited from the Movement Disorders Center at the University of Colorado Hospital. All patients were currently taking dopaminergic medications. We attempted to recruit TD and PIGD subtypes in equal number through phone interview pre-screening of symptoms.
At a screening visit, PD patients had TD and PIGD scores calculated as well as motor subtype assignment using previously published methods (Jankovic et al., 1990) . One patient was classified as indeterminate and excluded from further analyses, leaving 14 classified as PIGD and 14 as TD. Twenty-one age-and sex-matched healthy controls were recruited from patient spouses and the local community through advertisements and electronic postings. Written informed consent was obtained from all participants as approved by the Colorado Multiple Institutional Review Board and complied with the Declaration of Helsinki.
| Exclusion criteria
Exclusion criteria for all participants included: (a) untreated neurological 
| Experimental design 2.3.1 | Clinical assessments
All study participants had their handedness evaluated using the Edinburgh Handedness Inventory and were screened for cognitive impairment using the Montreal Cognitive Assessment. PD patients had their motor and non-motor symptoms rated using the Movement Disorder Society-Revised Unified Parkinson Disease Rating Scale (MDS-UPDRS) (Goetz et al., 2008) . At a screening visit, patients underwent motor assessments (MDS-UPDRS Part III) in a practically defined off state (at least 12 hr following the last dose of any dopaminergic medication, "OFF"), and again 1 hr after ingestion of 200 mg/50 mg levodopa/carbidopa immediate release formulation. Patients were asked to not alter their medication regimens between the screening visit and the MR scanning visit, but nevertheless were re-assessed in the OFF and ON state on the day of scanning using the MDS-UPDRS Part III to account for day-to-day differences in their motor symptoms.
| Data acquisition
Imaging data for 38 of the participants were acquired on a 3.0T GE Signa HDx system with an 8-channel head coil. The imaging data for the remaining nine participants (two healthy controls, two TD patients, and five PIGD patients) were acquired on a 3.0T Siemens Skyra system with a 20-channel head/neck coil due to replacement of the scanner. Participants' task performance was monitored visually via a window in the MRI control room and by simultaneous electromyography (EMG) recordings during fMRI scanning using a BIOPAC EMG Amplifier and AcqKnowledge software (BIOPAC Systems, Inc., Goleta, CA). A pair of small adhesive, MRI-compatible EMG electrodes were placed over the left and right first dorsal interosseous muscle and a reference ground electrode was placed over a bony protuberance at either the wrist or elbow. The EMG signal data was monitored in real time and also reviewed post hoc to ensure participant compliance with the tapping task. One PIGD patient was excluded from the analysis due to movement detected in the left hand during the right hand tapping task, reducing the PIGD sample to 13.
| Preprocessing
The first four volumes were discarded to account for saturation effects.
The remaining functional images underwent slice-timing correction, realignment to the mean and linear coregistration to the individual's T 1 -weighted anatomical image within SPM8. Following the Unified Segmentation protocol (Ashburner & Friston, 2005) , forward deformations from the individual's T 1 -weighted structural image normalization to MNI template space were applied to the coregistered functional scans before smoothing with a 6 mm full width at half maximum kernel.
An autoregressive AR(1) model was used to account for serial correlation.
| Movement analysis
Head movement within the scanner was minimized by foam padding.
As a first pass, participants with scans containing movement 3 mm of translation or 3 degrees of rotation were excluded. One PIGD participant did not meet these criteria and was removed from any further analysis, leaving 12 PIGD patients. Subsequently, participants' realignment parameters were evaluated using the Artifact Detection Toolkit (https://www.nitrc.org/projects/artifact_detect/) to identify any volume with greater than 1 mm of movement from the previous TR. Each of these identified outlier volumes was then censored via a nuisance covariate in the participant's first-level analysis. All remaining participants had 75% of their respective volumes passing the censoring criteria. In total, 14 TD, 12 PIGD, and 21 healthy control participants passed all data quality standards.
| First-level and random effects modeling
Brain activation during tapping > rest was evaluated after convolving 30 s boxcar functions with a canonical hemodynamic response function for each block. Covariates of no interest included six rigid-body realignment parameters and any censored volume regressors. All first-level analyses were visually inspected to ensure general data quality and left hemisphere motor circuit activation. Group differences for tapping > rest were assessed using a factorial model with three factors: PD diagnosis (healthy controls or PD), subtype (none, TD, or PIGD), and medication status (OFF or ON). This model allowed us to test for activation differences between healthy controls and all PD patients without presuming identical patterns for the two PD subtypes. Scanner type and recorded tapping performance were entered as covariates of no interest. Voxels within a dilated gray matter mask were used in the whole brain analyses.
| Region of interest definition and analysis
Four region of interests (ROIs), including bilateral pPut and caudate head (HCd), showing functional coactivation with the terms sensorimotor processes and action value, respectively, were derived from a prior study with a meta-analytic framework (Pauli, O'Reilly, Yarkoni, & Wager, 2016) . The masks were eroded by 1 mm in three dimensions to limit overlap with other striatal regions. Beta weights of right finger tapping activity were extracted from each ROI and tested for effect of diagnosis, subtype, and drug.
| Psychophysiological interaction
Because our task involved unilateral right finger tapping, we used the left pPut as the seed region to determine the effect of levodopa on effective connectivity within the CSTC circuit. Briefly, effective connectivity within the context of PPI reflects experimentally-induced changes in functional connectivity (i.e., increased or decreased connectivity during tapping vs. rest) between a seed and other brain regions (Friston et al., 1997) . Using the gPPI toolbox (McLaren, Ries, Xu, & Johnson, 2012) , the first eigenvariate from each ROI was extracted, deconvolved (Kim & Horwitz, 2008) , and used as the physiologic regressor in the PPI analysis. The PPI analysis also included a task regressor consisting of the tapping block design, and the interaction between the physiologic and task regressors (O'Reilly et al., 2012).
Nuisance regressors for the six realignment parameters, cerebrospinal fluid, and white matter signal were included in the first-level model. Contrasts from the first-level interaction terms, reflecting increased connectivity during tapping compared with rest, were entered into the factorial analysis subtype (TD vs. PIGD) and drug (OFF vs. ON). Scanner type and tapping performance were covariates of no interest.
Parameter estimates from corrected clusters were extracted and plotted to determine magnitude and direction of the interaction.
| Statistical analysis
We analyzed differences in age and Montreal Cognitive Assessment scores between the three groups (healthy controls, TD, and PIGD). We analyzed group differences in recorded taps using ANCOVA, adjusting for age. Chi-squared statistics were used to test for significantly different distribution of female participants, MRI scanner, or symptom onset side between groups. PD-specific clinical characterizations (Hoehn & Yahr, MDS-UPDRS scores, and levodopa equivalent daily dose) were compared via a two-sample t-test with subtype as the factor. Effects of levodopa on MDS-UPDRS symptoms and tapping behavior between the PD subtypes were assessed with repeated-measures ANOVA.
Tukey's honest significant difference (HSD) post hoc testing was applied to characterize significant group differences. Correlations between clinical metrics and extracted parameter estimates (i.e., beta weights) from significant clusters in the random effects were compared using Spearman's rho. Group differences of the mean parameter estimates for each ROI was conducted using ANOVA and Tukey's HSD post hoc test. All statistical analyses were thresholded at p 5 .05, unless otherwise specified, and completed in SPSS 23 (IBM Corp., Armonk, NY). Whole brain statistical threshold contrasts compared all PD versus healthy controls for each medication state separately, followed by pairwise-comparisons between each subtypes and healthy controls for each medication state. Statistical thresholds for reporting clusters of BOLD activation were set at a voxel-level p < .001 followed by clusterlevel a < .05, corrected for multiple comparisons using 3dClustSim as implemented in AFNI version 16.1.01. For the PPI whole-brain results, the motor subtype*medication status interaction was tested prior to any main effects. Subtype and medication status main effects were assessed in areas not showing a significant interaction. Significant effective connectivity changes were reported for voxel-wise peak p 5 .005, cluster-level corrected at a < .05.
| R E S U L T S 3.1 | Demographics & symptomatology
Twenty-six patients (14 TD and 12 PIGD) and 21 healthy controls were included in the final analysis. Healthy controls, TD patients, and MDS-UPDRS I -9 6 5 9 6 4 1 0 6 7 .16
MDS-UPDRS II
MDS-UPDRS III-OFF -33 6 9 3 2 6 9 3 4 6 10 .61
MDS-UPDRS III-ON -24 6 8 2 4 6 10 24 6 8 .45
MDS-UPDRS IV -2 6 2 2 6 2 2 6 3 .15
Group difference p-values are reported for a three-way ANOVA (healthy controls and PD subtypes); PD-specific measures were compared by t-test; Chi-squared tests were used for categorical comparisons.
PIGD patients did not differ in age, sex, handedness, Montreal Cognitive Assessment scores, or scans acquired on different MR systems ( 
| Task performance
The number of recorded button presses while tapping during the OFF scan differed between the three groups, even after accounting for age 
| Whole brain BOLD activation analysis: OFF levodopa
During right hand finger tapping > rest, healthy controls ( Figure 1a Table 2 ). There was decreased activation in left motor cortex in TD OFF relative to controls, but not PIGD OFF relative to controls (Table 2) .
| Whole brain BOLD activation analysis: ON levodopa
No brain activation differences during the tapping task were observed between healthy controls and all PD ON; however, PD subtype comparisons showed several differences (Table 2) . Compared with healthy controls, PIGD ON had greater activation within the left putamen, while TD ON had decreased activation in the right premotor cortex (BA 6) and superior parietal lobe (BA 7). PIGD ON also had increased activation in the right superior temporal gyrus (BA 42 and 21) compared to TD ON. Within-subject pairwise comparisons between ON and OFF states showed no effect of drug on brain activation within or between PD subtypes.
| Correlation between clinical measures and brain activity during finger tapping
There were no significant correlations between parameter estimates from significant clusters in ON or OFF and clinical measures.
| ROI analysis
During the ON state, there was a significant group difference in mean parameter estimates in the left pPut ROI (F 2, 44 5 5.2, p 5 .009). 
| PPI analysis
The subtype*medication status interaction term was significant in multiple motor regions ( between PD motor subtypes that can be elicited using a dopaminergic medication challenges during a motor task.
Compared to healthy controls, PD OFF across subtype demonstrated hypoactivation of the left primary motor cortex during the right handed motor task (BA 4; Figure 1b ). A number of prior studies have reported increased activation within contralateral primary motor cortex in PD (Eckert et al., 2006; Haslinger et al., 2001; Sabatini et al., 2000; Yu et al., 2007) ; however, the patient cohorts included in these reports were largely non-TD patients. To investigate whether our observation could be attributable to one or both subtypes, we separately compared TD OFF and PIGD OFF to controls and found that the motor cortex hypoactivation relative to healthy controls was largely driven by the TD OFF patients. Our results are, therefore, in line with a recent study of 18 TD and 2 non-TD patients reporting motor cortex hypoactivation in PD after dopamine replacement therapy washout relative to controls (Burciu et al., 2015) . Notably, our Parkinson's patients ON did not evidence any activation changes within primary or secondary motor Seed region 5 left posterior putamen; peak p 5 .005, cluster-corrected a < .05; "ON" connectivity was observed 1 hr after 200 mg levodopa. VLN 5 ventrolateral nucleus.
cortices compared with controls, potentially reflecting a restoration of motor network function in the TD ON group and consistent with the "normalizing" effects of dopamine replacement therapy noted in other functional imaging studies where activation changes were no longer detectable after dopaminergic medication (reviewed in Prodoehl, Burciu, & Vaillancourt, 2014; Tessitore, Giordano, De Micco, Russo, & Tedeschi, 2014) .
The pathological hallmark in PD is the progressive loss of dopaminergic neurons in the substantia nigra resulting in a deficiency of dopamine within the striatum-the major input structure for the basal ganglia (Braak et al., 2006) . The putamen in particular has been implicated in motor pathology (reviewed by Jellinger, 2012) in PD, with specific emphasis on its posterior aspects due to the corticotopic organization of the basal ganglia (Haber, 2003) and the posterior to anterior, caudal to rostral pattern of disease progression (Nandhagopal et al., 2009; Spiegel et al., 2007; Sterling et al., 2013) . Changes in the putamen have been linked with symptomatology that defines PD motor subtypes (Bernheimer, Birkmayer, Hornykiewicz, Jellinger, & Seitelberger, 1973; Rosenberg-Katz et al., 2013; Vervoort et al., 2016) .
Specifically, SPECT studies found evidence of an association between putaminal uptake of a dopamine transporter tracer and worse rigidity and more pronounced dopaminergic loss in the posterior putamen in non-TD and mixed subtype compared with TD (Eggers et al., 2011; Spiegel et al., 2007) . These findings, together with our subtype comparisons that revealed that left putamen activity during finger tapping with the right hand was significantly increased by levodopa only in PIGD patients, provide further evidence of a role for the putamen in phenotypic subtype manifestations.
A key, novel finding in our study is that levodopa led to divergent tapping-induced coupling responses within the motor network in PD patients with PIGD and TD motor phenotypes that could not be accounted for by differences in disease stage or duration. TD ON relative to TD OFF showed significantly increased effective connectivity between the left pPut seed and other motor network regions while PIGD ON relative to PIGD OFF showed no significant changes ( Figure   3b ). This finding provides evidence of an underlying pathophysiological difference in the way distinct motor subtypes in PD respond to levodopa. Clinically, symptoms of the PIGD subtype are known to respond more poorly to levodopa than other motor symptoms. It is possible that differences in levodopa responsiveness between PD motor subtypes could stem from less amino-acid decarboxylase bioavailability, and subsequently lower conversion of levodopa to dopamine, in PIGD patients (Iacono et al., 1997) . This, however, is unlikely to have significantly confounded our results because our patients were all in early to mid-stages of disease, there was no significant difference found in LED between subtypes, and there was no significant difference in the levodopa-induced changes in MDS-UPDRS motor scores between our cohorts. We therefore speculate that this poor response may be due to a functional disconnection of the posterior putamen, as evidenced in our study by increased putaminal activation without concomitant increases in motor network connectivity in PIGD ON. In other words, neural signals propagating to or originating from the putamen in PIGD patients are not being relayed to the major output pathways of the basal ganglia (globus pallidus interna and substantia nigra pars reticulate), on to the thalamus, and back to the cortex (Redgrave et al., 2010) .
TD ON relative to TD OFF, in contrast to PIGD ON relative to PIGD OFF, showed increased effective connectivity between the left pPut seed and the distributed motor network, including bilateral thalami, left dorsolateral prefrontal cortex, middle cingulate gyrus, and supplementary motor area. This finding parallels findings of decreased resting-state functional connectivity measures in the posterior putamen in non-TD patients (Hacker et al., 2012) , but not in TD patients Zhang et al., 2014) . Additionally, our results coincide with the putamen signaling being less affected in TD than PIGD Spiegel et al., 2007; Sterling et al., 2013) , and suggest a more responsive putamen enables CSTC connectivity to be more modulated by levodopa.
Our study is limited by a modest sample size, though the groups are larger than many other prior reports (e.g., (Lewis et al., 2011; Sabatini et al., 2000; Tessa et al., 2012; Yu et al., 2007) . To mitigate possible false positives, we used high statistical significance thresholds as recently suggested for fMRI activation studies (Eklund, Nichols, & Knutsson, 2016; Woo, Krishnan, & Wager, 2014) . Despite our careful efforts to match performance through experimental design, PIGD patients OFF had fewer recorded taps than TD OFF and healthy controls. It is unclear whether the difference is due to insufficient pressure on the button or slowness in release (Yu et al., 2007) , but EMG recordings during tapping support that all participants were fully compliant with the task. Nevertheless, we included recorded taps as a covariate in the second-level analyses to minimize the effects that any performance differences may have had on brain activations related to motor
output. An additional limitation is that all patients were scanned in a practical OFF state at a minimum of 12 hr after their last dose of medication. While the longer half-lives of dopamine agonists and the known long duration responses to anti-parkinsonian medications could have different lingering effects, we did not find a significant difference between the types of dopaminergic medications taken by the different subtypes (Table 1) . Nevertheless, it remains to be investigated whether PD motor subtypes differ in their short and long duration withdrawal responses. Lastly, disease stage as measured by Hoehn and Yahr score was significantly higher in our PIGD cohort. It is possible that this disease stage difference could have impacted our findings. We, however, suspect this difference stems from a limitation in the Hoehn and Yahr scale in that it is weighted heavily toward the symptoms of postural instability and gait disability as the primary index of disease severity (Goetz et al., 2004) . In our study cohorts, the other indices of disease severity including disease duration, LED requirements, MDS-UPDRS motor scores, and MDS-UPDRS total scores were not significantly different. Thus, the differences in Hoehn and Yahr scores is unlikely to have contributed significantly to our findings.
In conclusion, we provide novel evidence of divergent motor network effective connectivity responses to levodopa in two different PD motor subtypes. Our findings extend our understanding of distinct pathophysiological changes underlying distinct motor phenotypes seen in PD. Specifically, levodopa produced significantly increased activation in the contralateral putamen in PIGD patients relative to TD patients during right hand finger tapping without altering effective connectivity within the motor network as it did in the TD patients. This supports the presence of greater altered motor circuit dynamics in the PIGD subtype than in the TD subtypes. Together, our results suggest that PD motor subtypes may be identified by their divergent motor network effective connectivity responses to levodopa during a tapping task.
Greater characterization of mechanisms underlying the distinct phenotypes could result in better targeted treatments and clinical trials.
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